A Study of Women With an Early Diagnosis of Breast Cancer, Taking Celecoxib Between the Biopsy and Lumpectomy/Mastectomy

Status:
Completed

Trial end date:
2005-12-01

Target enrollment:

Participant gender:

To assess the effects of short term administration of celecoxib 400 mg bid between biopsy and reexcision.

Phase 1

University of Kansas

Pfizer

Celecoxib